FOP News

Cardiac Changes in FOP

Patients with ACVR1R206H mutations have an increased prevalence of cardiac conduction abnormalities on electrocardiogram in a natural history study of FOP

Read more Share

Update from Keros Therapeutics on KER-047

Keros completes Phase 1 Clinical Trial

Read more Share

Coronavirus (COVID-19) Precautions for FOP Families (Updated July 17, 2020)

Read more Share

You're Invited to Participate!

Study on Effects of COVID-19 on Endocrine Disorders

Read more Share

Ipsen, FOP and the Journal of the Endocrine Society 

Read more Share

Tele-mentoring Webinar on FOP Offers CME Credit

Invite Your Local Physician

Read more Share

Coronavirus (COVID-19) Precautions for FOP Families (Updated March 27, 2020)

Read more Share

Important Press Release and Letter from Ipsen Announcing They Will Reinitiate Dosing in the MOVE Trial

Dosing to begin again in patients 14 years of age and older currently enrolled in the trial

Read more Share

STOPFOP Recruitment Paused

Read more Share

International Clinical Council on FOP Issues COVID-19 Precautions for FOP Families

Read more Share

Make a Difference

Donate Connect Fundraise

Already a Member? Sign In

Sign Up for FOP Connection, Our Monthly eNewsletter